Valuation: Vext Science, Inc.

Market Cap 44.96M 40.02M 37.09M 33.61M 63.17M 4.26B 64.22M 445M 175M 2.23B 169M 165M 7.11B P/E 2026 *
-
P/E 2027 * 18.2x
Enterprise Value 64.48M 57.39M 53.19M 48.2M 90.58M 6.11B 92.1M 638M 251M 3.2B 242M 237M 10.2B EV / Sales 2026 *
1.2x
EV / Sales 2027 * 0.82x
Free-Float
40.74%
Yield 2026 *
-
Yield 2027 * -
1 week+10.87%
Current month+8.51%
6 months-5.56%
1 week 0.24
Extreme 0.24
0.26
1 month 0.21
Extreme 0.21
0.26
Current year 0.21
Extreme 0.21
0.4
1 year 0.19
Extreme 0.19
0.4
3 years 0.1
Extreme 0.1
0.42
5 years 0.1
Extreme 0.1
0.92
10 years 0.1
Extreme 0.1
2.1
Manager TitleAgeSince
Chief Executive Officer - 18/02/2020
Director of Finance/CFO - 25/08/2023
Investor Relations Contact - -
Director TitleAgeSince
Chairman 45 11/12/2015
Director/Board Member - 14/02/2020
Chairman 69 20/08/2024
Date Insider Type Main position Quantity % Market Cap. Importance
5/1/26 Sell

Director

1,334,000 0.8075%
5/1/26 Sell

Founder

20,340 2.9973%
5/1/26 Other

Director

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+10.87%-8.93%-10.53% 44.96M
+2.23%+8.22%+14.88%+37.22% 121B
+2.39%+1.09%+7.53%+93.15% 101B
+1.63%+2.59%+115.23%+895.88% 58.51B
+0.94%+2.89%+24.53%+91.64% 26.17B
+1.35%+3.03%+11.07%+61.68% 26.21B
+2.23%+2.03%+34.74%+399.03% 21.93B
-0.41%-3.79%-21.87%-5.09% 20.37B
+1.71%-0.99%+7.35%+88.66% 19.16B
0.00%-1.25%-4.70%+32.94% 17.12B
Average +1.21%+0.58%+17.98%+168.46% 41.15B
Weighted average by Cap. +1.80%+2.85%+25.79%+197.42%

Financials

2026 *2027 *
Net sales 53.8M 47.89M 44.38M 40.22M 75.58M 5.1B 76.85M 533M 209M 2.67B 202M 198M 8.51B 65.6M 58.39M 54.11M 49.04M 92.16M 6.21B 93.7M 649M 255M 3.25B 246M 241M 10.37B
Net income -900K -801K -742K -673K -1.26M -85.26M -1.29M -8.91M -3.5M -44.62M -3.38M -3.31M -142M 3.22M 2.87M 2.66M 2.41M 4.52M 305M 4.6M 31.88M 12.52M 160M 12.08M 11.83M 509M
Net Debt 19.52M 17.37M 16.1M 14.59M 27.42M 1.85B 27.88M 193M 75.89M 968M 73.21M 71.69M 3.09B 8.69M 7.73M 7.17M 6.5M 12.21M 823M 12.41M 86.01M 33.79M 431M 32.59M 31.92M 1.37B
Projected Income Statement - Annual - Vext Science, Inc.
Logo Vext Science, Inc.
Vext Science, Inc. is a cannabis operator with vertical operations in Arizona and Ohio. The Company's expertise spans from cultivation through to retail operations in its key markets. The Company owns and operates cultivation facilities, fully built-out manufacturing facilities as well as dispensaries in both Arizona and Ohio. The Company produces a range of branded offerings, including its Vapen, Revibe, Herbal Wellness Center, and Appalachian Pharm lines. The Company manufactures Vapen, one of the THC concentrates, edibles, and distillate cartridge brands in Arizona. It produces CBD products under the Vapen CBD and Hempy Endings brands, manufactured at its Vapen Kentucky facility. Through strategic licensing agreements, it manufactures the Microbar brand in Arizona. The Company extends its services to the cannabis industry by offering management, advisory, cultivation, non-cannabis products, and dispensary services through operating agreements and direct sales to various entities.
Employees
-
Date Price Change Volume
20/10/26 CAD 0.2550 +2.00% 17,000
19/10/26 CAD 0.2500 +4.17% 5,000
16/10/26 CAD 0.2400 -2.04% 10,500
15/10/26 CAD 0.2450 +2.08% 7,500
14/10/26 CAD 0.2400 +4.35% 86,500
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Vext Science, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.2550CAD
Average target price
0.9500CAD
Spread / Average Target
+272.55%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Vext Science, Inc.
  1. Stock Market
  2. Stocks
  3. VEXT Stock